Favorable outcomes of NPM1 mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.
Irum KhanA KaempfSanjeev RaghuwanshiMikhail S ChesnokovX ZhangZ WangA DomlingJeffrey W TynerC CamachoAndrei L GartelPublished in: Blood cancer journal (2023)
Keyphrases
- acute myeloid leukemia
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- transcription factor
- type diabetes
- metabolic syndrome
- patient reported outcomes
- oxidative stress
- adipose tissue
- acute lymphoblastic leukemia
- skeletal muscle
- allogeneic hematopoietic stem cell transplantation
- heat stress
- heat shock protein